Literature DB >> 6703100

Reversible steroid dementia in patients without steroid psychosis.

N R Varney, B Alexander, J H MacIndoe.   

Abstract

Six patients developed dementia-like cognitive changes that appeared to result from administration of steroid medications. Four of the patients never showed symptoms of steroid psychosis; the remaining two continued to show steroid dementia well after their steroid psychoses had resolved. The dementia was characterized by deficits in memory retention, attention, concentration, mental speed and efficiency, and occupational performance. All six patients eventually recovered normal mental status following discontinuation or reduction of steroid medications. Larger prospective studies are needed to determine the prevalence and nature of the syndrome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703100     DOI: 10.1176/ajp.141.3.369

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  16 in total

Review 1.  [Effects of high-dose cortisone therapy on cognition].

Authors:  I Uttner; H Tumani
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 2.  Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.

Authors:  S B Patten; C I Neutel
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

Review 3.  Steroid psychosis: a review for neurosurgeons.

Authors:  Donald A Ross; Justin S Cetas
Journal:  J Neurooncol       Date:  2012-07-05       Impact factor: 4.130

Review 4.  Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Authors:  Samir D Bhangle; Neil Kramer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

5.  A comparison of clinician-rated neuropsychological and self-rated cognitive assessments in patients with asthma and rheumatologic disorders.

Authors:  Alan B Frol; Aracely Vasquez; Yonatan Getahun; Maria Pacheco; David A Khan; E Sherwood Brown
Journal:  Allergy Asthma Proc       Date:  2013 Mar-Apr       Impact factor: 2.587

6.  Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus.

Authors:  R M Carbotte; S D Denburg; J A Denburg; C Nahmias; E S Garnett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

Review 7.  Psychiatric aspects of organ transplantation in critical care.

Authors:  Andrea DiMartini; Catherine Crone; Marian Fireman; Mary Amanda Dew
Journal:  Crit Care Clin       Date:  2008-10       Impact factor: 3.598

8.  Mood and Cognitive Changes During Systemic Corticosteroid Therapy.

Authors:  E Sherwood Brown; Patricia A. Chandler
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-02

Review 9.  Hospitalization and cognitive decline: Can the nature of the relationship be deciphered?

Authors:  Sarah B Mathews; Steven E Arnold; C Neill Epperson
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

Review 10.  Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis.

Authors:  Hayrettin Tumani; Ingo Uttner
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.